NanoRETE Inc Profile last edited on: 12/4/13
CAGE: 6ES98
UEI:
Business Identifier: Nano-sensors for pathogen and toxin detection 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 08
County:
Congr. District: 08
County:
Public Profile
nanoRETE, Inc. provides real-time detection of pathogens using customized nanoparticle biosensors. The company has developed a platform that has the ability to test for numerous pathogens (anthrax, E. Coli, salmonella, tuberculosis, etc.) using a simple-to-use handheld device which generates screening results in about one hour. Currently, biohazards cannot be "field tested" because pathogens must be cultured and developed in a lab, away from the hazard source. Initial applications of the technology are targeted towards novel diagnostics and homeland security.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
YesPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2013 | 2 | DHA | $900,000 | |
| Project Title: Development of a field-appropriate biosensor for detecting Mycobacterium tuberculosis infection | ||||
Key People / Management
Fred Beyerlein -- Chief Executive Officer
Linda Chamberlain -- CEO
Evangelyn Alocilja -- Chief Scientific Advisor
Finny Mathew -- Director of Laboratory Operations
Houng-Yau Mei
Linda Chamberlain -- CEO
Evangelyn Alocilja -- Chief Scientific Advisor
Finny Mathew -- Director of Laboratory Operations
Houng-Yau Mei
